Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Samara
Emil Samara, Emeryville, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080214481 | Methods of Treatment of Endobronchial Infections - The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days. | 09-04-2008 |
| 20110097412 | METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS - The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days. | 04-28-2011 |
| 20120148641 | METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS - The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days. | 06-14-2012 |
Emile A. Samara, Springfield, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100178111 | SOIL DRAINAGE SYSTEM - A soil drainage system which comprises a core pipe ( | 07-15-2010 |
Vicky Samara, Pallini Attikis GR
| Patent application number | Description | Published |
|---|---|---|
| 20100196469 | Pharmaceutical Formulation containing an HMG-COA Reductase Inhibitor and method for the preparation thereof - The present invention relates to the formulation of solid dosage forms comprising a therapeutically effective amount of an HMG-CoA reductase inhibitor, and especially Atorvastatin or Fluvastatin or salts thereof, in combination with colloidal clay such as Attapulgite, and a process for the preparation thereof by direct compression. | 08-05-2010 |
| 20100297225 | SUSTAINED-RELEASE PHARMACEUTICAL FORMULATION CONTAINING AN ANTIMUSCARINIC AGENT AND A WETTING AGENT AS WELL AS A PROCESS FOR THE PREPARATION THEREOF - The present invention relates to improved sustained release dosage forms such as tablets and capsules, and in particular to a pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an antimuscarinic agent, such as Tolterodine or pharmaceutical acceptable salt, derivative, prodrug and metabolite thereof in combination with a wetting agent, such as Sodium Docusate to improve the release of the active ingredient and a method for the preparation thereof. | 11-25-2010 |
| 20110033538 | Pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof - The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation. | 02-10-2011 |
| 20110065751 | Improved pharmaceutical composition containing a selective estrogen receptor modulator and method for the preparation thereof - The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a selective estrogen receptor modulator, and especially Raloxifene or a pharmaceutical acceptable salt thereof, in combination with a super disintegrant such as Primojel, and a process for the preparation thereof by wet granulation. | 03-17-2011 |
Vladimir Samara, Leuven BE
| Patent application number | Description | Published |
|---|---|---|
| 20120283973 | PLASMA PROBE AND METHOD FOR PLASMA DIAGNOSTICS - Device and method for monitoring a plasma in a chamber of a plasma reactor is are disclosed. In one aspect, the method includes measuring plasma parameter data at a surface of a single planar Langmuir probe in contact with the plasma. A biasing capacitor is connected between the single planar Langmuir probe and a DC-bias source. Subsequently a discharge current of the biasing capacitor as a result of the DC-bias is measured, and a probe potential at the single probe during the discharge is measured. The measurements can be used to detect presence and/or thickness of a dielectric film on the probe surface. | 11-08-2012 |